Gold Mining News – Lifestyle

Author: Ensysce Biosciences

Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology

May 12, 2026
Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam

May 8, 2026
Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study

April 16, 2026
Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs

April 7, 2026
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results

March 31, 2026